Trial site
University of Virginia Comprehensive Cancer Center
- 17running trials
- 5closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Ovarian cancer5 trials
- Bladder cancer3 trials
- Endometrial cancer3 trials
- Liver and biliary tract cancer3 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Acute myeloid leukaemia2 trials
- Cervical cancer2 trials
- Triple-negative breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Brain metastases1 trial
- and 13 more
- Phase
- Phase 27 trials
- Phase 37 trials
- Phase 13 trials
- Phase 1/23 trials
- Early phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting12 trials
- Active, not recruiting4 trials
- Completed4 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Alliance Foundation Trials, LLC.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Crinetics Pharmaceuticals Inc.1 trial
- and 16 more
Running trials
Recruiting
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
Recruiting
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruiting
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Active, not recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Recruiting
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Recruiting
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Active, not recruiting
Recruiting
Recruiting
Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Recruiting
Active, not recruiting
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Recruiting
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer3 recruiting
- Lung cancer2 recruiting
- Prostate cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Terminated
Completed
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026